[e-med] CISMA Abuja : Réunion de MSF sur les traitements antirétroviraux dans les pays à faible revenus

["ReMeD" <remed@remed.org>]

[Traduction partielle d'un message diffusé sur IP-Health le 23 novembre. L'ensemble du message en anglais suit la traduction, MD]


Vivant après cinq ans : les traitements antirétroviraux dans les pays à faible revenus

Dimanche 4 décembre 2005, de 11h00 à 15h00 au centre de conférence international, prefab 1(ICC3)

Programme

11h00 Accueil par le Dr Roger Teck, MSF

Première partie : expériences à partir des programmes de traitements en Afrique

11h05 : traitement au long cours : résultats et défis. Que se passe-t-il quand la première ligne de traitement n'est plus efficace ?
Brève présentation suivie d'une discussion
Soutenir les ARV au Cameroun, par Isaac Tita, HIV/AIDS Activiste
Comment le Cameroun apporte les ARV aux patients ? 
11h45 : Discussion
12h30 : Le défi d'un accès accru aux traitements pour les enfants 
Cette session est très brève, les résultats des programmes de MSF seront présentés.


Seconde partie : les stratégies pour atteindre plus de personnes

13h15 : décentralisation et simplification de la délivrance des ARV.
14h00 : Discussion
14h30 : Le contexte du Nigeria

14h55 :  Conclusion

---
Rachel M. Cohen
U.S. Director, Campaign for Access to Essential Medicines Doctors Without Borders/M=E9decins Sans Fronti=E8res (MSF)
333 Seventh Avenue, 2nd Floor * New York, NY * 10001-5004 * USA
Tel: +1-212-655-3762
Mobile: +1-917-331-9077
Fax: +1-212-679-7016
E-mail: rachel.cohen@newyork.msf.org


****************************************************************************************

Ip-health Invitation to MSF Satellite Event at ICASA 2005 (Abuja, Nigeria) -- Sunday, December

INVITATION TO MSF'S SATELLITE EVENT AT ICASA:


ALIVE AFTER FIVE YEARS - ANTIRETROVIRAL TREATMENT (ART) IN RESOURCE-POOR SETTINGS

Sunday, December 4th, 2005, from 11h00-15h00 At the International Conference Centre, Prefab 1(ICC 3)

PROGRAMME

11:00 Welcome by Dr Roger Teck, MSF

PART ONE:
EXPERIENCES FROM AFRICAN HIV TREATMENT PROGRAMMES

11:05  Long-term Treatment: Outcomes and Challenges What happens when first-line medicines no longer work?

Short presentations followed by open discussion.

-- Pushing for ART in Cameroon
Isaac Tita, HIV/AIDS Activist
How did Cameroon bring ART to patients?

-- Long-term outcomes in adults under ART in resource-poor settings Dr Pierre Humblet, Coordinator of the MSF HIV/AIDS Working Group Three-year treatment outcomes in patients under ART in MSF programmes

-- Challenges in providing long-term ART:
The experience of Khayelitsha,  South Africa Dr Eric Goemaere, Head of mission, MSF South Africa Long-term treatment outcomes in the Khayelitsha programme: What are the challenges around adherence? When to switch to second-line treatment? How to access affordable second-line treatments?

-- Cost implications of new drugs and increased need for monitoring Fernando Pascual, pharmacist, and Daniel Berman, coordinator, MSF Campaign for Access to Essential Medicines Gaining access to newer drugs (especially second-line) and monitoring
tools: challenges and cost implications.

11:45 Open Discussion

12:30  The Challenge of Increasing Access to Treatment for Children

This session is very short but participants are invited to attend the abstract sessions where results from MSF's programmes treating children will be presented.

-- Main obstacles to scaling up paediatric ART Dr Felipe Garcia, AIDS physician, MSF Campaign for Access to Essential Medicines

"Babies with AIDS: No tests, no pills - no future?" 8-minute film


PART TWO: STRATEGIES TO REACH MORE PEOPLE

13:15        Decentralization / Simplification of ART Delivery

-- Impact of cost sharing on access to care in DRC and Malawi: MSF's experience with financial barriers Dr Mit Philips from MSF's Analysis and Advocacy Unit, Brussels

-- Decentralization of ART in a rural district in Malawi: the MSF experience in Thyolo Dr Roger Teck, former MSF Head of mission in Thyolo

-- The challenge of decentralization and rationalization of resources:
MSF's experience in Homa Bay (Kenya)
Dr Bintari Dwihardiani, former HIV coordinator for MSF in Homa Bay, now medical coordinator


14:00  Open Discussion


14:30  The Nigerian Context

-- Access to ART in Nigeria: MSF's experience in Lagos Els Botha Standaert, coordinator of the MSF project in Lagos

-- Role and place of PLHA groups and associations in access to treatment and treatment delivery in Nigeria `Rolake Odetoyinbo, coordinator for Treatment Action Movement (TAN), a coalition of Nigerian NGOs working on access to treatment.

14:55  Conclusion

---
Rachel M. Cohen
U.S. Director, Campaign for Access to Essential Medicines Doctors Without Borders/M=E9decins Sans Fronti=E8res (MSF)
333 Seventh Avenue, 2nd Floor * New York, NY * 10001-5004 * USA
Tel: +1-212-655-3762
Mobile: +1-917-331-9077
Fax: +1-212-679-7016
E-mail: rachel.cohen@newyork.msf.org